The utilisation of assays such as plasma miR-107 measurement may potentially improve the accuracy of conventional prostate cancer detection and case finding when combined with PSA level measurement, although this hypothesis requires formal testing in larger prospective studies. This evidence concerns the gene KLK3 and Familial prostate cancer.